Algert Global LLC Next Cure, Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.38 - $5.27 $23,288 - $36,310	6,890 Added 43.11%	22,872 $107,000
Q1 2022 May 16, 2022	SELL	$4.76 - $6.24 $47,314 - $62,025	-9,940 Reduced 38.35%	15,982 $78,000
Q4 2021 Feb 14, 2022	BUY	$5.7 - $9.1 $23,028 - $36,764	4,040 Added 18.46%	25,922 $156,000
Q3 2021 Nov 15, 2021	BUY	$6.74 - $8.02 $147,484 - $175,493	21,882 New	21,882 $147,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.